Baylor College of Medicine: A Promising Combination Therapy for Triple-Negative Breast Cancer
April 28, 2022
April 28, 2022
HOUSTON, Texas, April 28 (TNSJou) -- The Baylor College of Medicine issued the following news:
Researchers at Baylor College of Medicine and collaborating institutions have identified a combination therapy for treating triple-negative breast cancer (TNBC) that results in durable tumor regression in an animal model of the condition.
The combination therapy attacked the tumor on two fronts. On one side, the chemotherapy drug cyclophosphamide eliminated tumor cells, while . . .
Researchers at Baylor College of Medicine and collaborating institutions have identified a combination therapy for treating triple-negative breast cancer (TNBC) that results in durable tumor regression in an animal model of the condition.
The combination therapy attacked the tumor on two fronts. On one side, the chemotherapy drug cyclophosphamide eliminated tumor cells, while . . .